Literature DB >> 3653728

Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye.

T Hida1, D B Chandler, S M Sheta.   

Abstract

Eighty-four rabbit eyes injected intravitreously with tissue-cultured fibroblasts following gas compression of the vitreous were examined clinically over a period of 1 month. Detailed clinical descriptions of the extent of retinal changes were recorded. Clinical landmarks were determined and arranged into a new classification of this model of proliferative vitreoretinopathy (PVR). The proposed classification will allow easier communication between research groups using this model to study the treatment and prevention of PVR.

Entities:  

Mesh：

Year:  1987        PMID： 3653728     DOI： 10.1007/BF02150154

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


  12 in total

1.  Retinal neovascularization after intravitreal fibroblast injection.

Authors:  Y Tano; D B Chandler; R Machemer
Journal:  Am J Ophthalmol       Date:  1981-07       Impact factor: 5.258

2.  The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy.

Authors:  D B Chandler; G Rozakis; E de Juan; R Machemer
Journal:  Am J Ophthalmol       Date:  1985-06-15       Impact factor: 5.258

3.  Intravitreal expanding gas bubble. A morphologic study in the rabbit eye.

Authors:  B Miller; J S Lean; H Miller; S J Ryan
Journal:  Arch Ophthalmol       Date:  1984-11

4.  The role of cellular proliferation in an experimental model of massive periretinal proliferation.

Authors:  D M Fastenberg; K R Diddie; K Dorey; S J Ryan
Journal:  Am J Ophthalmol       Date:  1982-05       Impact factor: 5.258

5.  Experimental Fibroplasia in the rabbit vitreous. Retinal detachment induced by autologous fibroblasts.

Authors:  P Algvere; E Kock
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-05-26

6.  Surgical removal of vitreous. Its effect on intraocular fibroblast proliferation in the rabbit.

Authors:  H T Hsu; K Dorey; N Sorgente; S J Ryan
Journal:  Arch Ophthalmol       Date:  1984-04

7.  A refined experimental model for proliferative vitreoretinopathy.

Authors:  D B Chandler; F A Quansah; T Hida; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

8.  Gas-mediated vitreous compression: an experimental alternative to mechanized vitrectomy.

Authors:  R J Thresher; M Ehrenberg; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

9.  Inhibition of intraocular proliferations with intravitreal corticosteroids.

Authors:  Y Tano; G Sugita; G Abrams; R Machemer
Journal:  Am J Ophthalmol       Date:  1980-01       Impact factor: 5.258

10.  Fluorouracil for the treatment of massive periretinal proliferation.

Authors:  M S Blumenkranz; A Ophir; A J Claflin; A Hajek
Journal:  Am J Ophthalmol       Date:  1982-10       Impact factor: 5.258
View more
  10 in total

1.  Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.

Authors:  S Kuriyama; T Ohuchi; N Yoshimura; Y Honda; M Hiraoka; M Abe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  The lack of an effect of intraocular steroids on irradiated fibroblasts in experimental proliferative vitreoretinopathy.

Authors:  D B Chandler; T Hida; G Rozakis; V S Forbes; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR).

Authors:  Khaled Nassar; Julia Lüke; Matthias Lüke; Mahmoud Kamal; Effat Abd El-Nabi; Mahmoud Soliman; Martin Rohrbach; Salvatore Grisanti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-07       Impact factor: 3.117

4.  A model of chronic hypotony in the rabbit.

Authors:  H C Kim; A Hayashi; A Shalash; E de Juan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-01       Impact factor: 3.117

Review 5.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

6.  Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.

Authors:  J A Khawly; P Saloupis; D L Hatchell; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

7.  A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation.

Authors:  Mei Chen; Jiangping Hou; Guilin Tan; Peng Xie; William R Freeman; James R Beadle; Karl Y Hostetler; Lingyun Cheng
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  Characterisation of the inflammatory cytokine and growth factor profile in a rabbit model of proliferative vitreoretinopathy.

Authors:  Chee Wai Wong; Ning Cheung; Candice Ho; Veluchamy Barathi; Gert Storm; Tina T Wong
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

9.  A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells.

Authors:  Alison Heffer; Victor Wang; Jayanth Sridhar; Steven E Feldon; Richard T Libby; Collynn F Woeller; Ajay E Kuriyan
Journal:  Transl Vis Sci Technol       Date:  2020-06-05       Impact factor: 3.283

10.  Endogenous or Exogenous Retinal Pigment Epithelial Cells: A Comparison of Two Experimental Animal Models of Proliferative Vitreoretinopathy.

Authors:  Chee Wai Wong; Joanna Marie Fianza Busoy; Ning Cheung; Veluchamy Amutha Barathi; Gert Storm; Tina T Wong
Journal:  Transl Vis Sci Technol       Date:  2020-08-31       Impact factor: 3.283
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.